Sanofi has appointed chief medical officer Ameet Nathwani to the additional role of chief digital officer, a newly created role.

The appointment follows other major pharma companies in creating the digital chief position, including Pfizer and Merck last October and Novartis and GlaxoSmithKline in 2017.

Nathwani joined Sanofi as chief medical officer in 2016. In his new role, he will focus on scaling Sanofi’s digital initiatives and developing the digital health strategy and capability. This will include developing external partnerships, building internal digital infrastructures, and exploring new business opportunities, according to Sanofi’s statement.

The role has two areas of focus: working to integrate technology with Sanofi’s scientific innovation and enhancing company-wide activities like drug discovery, operations, and customer engagement through the use of digital technology and analytics.

Prior to joining Sanofi, Nathwani spent 11 years at Novartis in roles including global development head of the cardiovascular and metabolic franchise. Earlier in his career, Nathwani worked at SmithKline Beecham and GlaxoSmithKline.

Nathwani was not available for additional comment.